Entera Bio Ltd (ENTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,585 | 9,135 | 10,691 | 12,309 | 14,323 |
| Receivables | N/A | 29 | 29 | 246 | 233 |
| Other current assets | 431 | 650 | 653 | 294 | 634 |
| TOTAL | $8,016 | $9,814 | $11,373 | $12,849 | $15,190 |
| Non-Current Assets | |||||
| PPE Net | 108 | 122 | 136 | 139 | 152 |
| Other Non-Current Assets | 441 | 509 | 97 | 139 | 198 |
| TOTAL | $549 | $631 | $233 | $278 | $350 |
| Total Assets | $8,565 | $10,445 | $11,606 | $13,127 | $15,540 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,896 | 1,725 | 1,446 | 17 | 1,064 |
| Accrued Expenses | N/A | N/A | N/A | 1,233 | N/A |
| TOTAL | $2,027 | $1,865 | $1,494 | $1,341 | $1,193 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 302 | 348 | 32 | 32 | 35 |
| TOTAL | $302 | $348 | $32 | $32 | $35 |
| Total Liabilities | $2,329 | $2,213 | $1,526 | $1,373 | $1,228 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,814 | 28,814 | 28,814 | 28,810 | 28,810 |
| Retained earnings | -102,391 | -100,012 | -97,687 | -95,497 | -92,462 |
| Other shareholders' equity | 41 | 41 | 41 | 41 | 41 |
| TOTAL | $6,236 | $8,232 | $10,080 | $11,754 | $14,312 |
| Total Liabilities And Equity | $8,565 | $10,445 | $11,606 | $13,127 | $15,540 |